TRT side effects: what the science says vs. what TikTok shows

What did @bradylanger actually say?

Brady laid out a three-week timeline on 100mg testosterone per week, prescribed by a doctor. Week one: nothing much. Week two: a "head rush" post-injection that his doctor apparently warned him about. Week three: a cluster of benefits he listed rapid-fire, including increased strength, better endurance, longer erections, improved sleep, confidence, and focus. He also drew a comparison that deserves its own section: "that kind of sounds like I used to get high on meth." He framed the whole thing as feeling like himself again before drugs took a toll. That framing matters, because it colors how everything else lands.

He is not claiming TRT cured anything. He is describing a personal experience at a legitimate prescribed dose, under medical supervision, over three weeks. That context is actually important when evaluating what he got right and what deserves more scrutiny.

Does the science back this up?

Mostly, yes, though the timeline is aggressive. Three weeks is early to see the full picture, and some of what he reports could be placebo. That said, the benefits he describes are real and documented, just not always this fast.

Testosterone's effects on libido and erections tend to show up earliest, sometimes within two to four weeks (Bhasin et al., 2010, New England Journal of Medicine). Strength and body composition changes typically take longer, six to twelve weeks in most clinical trials. Sleep improvements are documented but variable. The confidence and focus claims are where it gets murkier. Testosterone does interact with dopamine pathways and can improve mood in hypogonadal men (Shores et al., 2004, Archives of General Psychiatry), but the effect size varies considerably by baseline testosterone levels and individual response. At three weeks on 100mg weekly, some of what Brady feels is almost certainly real, some may be expectation bias, and the honest answer is it is hard to separate the two this early.

What did they get wrong or right?

The meth comparison is the most important thing to address here, and Brady actually handled it better than most would. He flagged it himself, almost as self-aware humor, rather than using it to hype TRT. He was not saying TRT is like meth. He was noting that motivation and energy felt familiar in a way that made him pause. That is worth taking seriously.

Here is what the science says: testosterone does not produce the acute dopamine surge that stimulants like methamphetamine cause. The mechanisms are categorically different. Meth floods the synapse with dopamine within minutes. Testosterone modulates androgen receptors over days and weeks. Comparing the two as equivalent experiences is not accurate, but Brady was not really doing that. He was describing a feeling, not a pharmacology lecture. Credit where it is due.

What he glossed over: he mentioned no side effects at all. No injection site reactions, no hematocrit changes, no mood fluctuations in the first week, no discussion of estradiol conversion. Three weeks in, those things may not be apparent yet, but a more complete account would include that TRT monitoring, specifically hematocrit, PSA in older men, and estrogen levels, matters (Traish et al., 2011, Journal of Andrology).

What should you actually know?

TRT is a legitimate medical treatment for hypogonadism, and the benefits Brady describes are consistent with what clinical literature shows in men with genuinely low testosterone. But there are things this video will not tell you.

• 100mg weekly is a common starting dose, but individual response varies enormously based on baseline levels, SHBG, and injection frequency.
• The "head rush" Brady describes post-injection is likely related to the peak serum spike from weekly dosing. It is not dangerous for most people, but it is a real pharmacokinetic phenomenon, not just motivation.
• TRT suppresses endogenous testosterone production and affects fertility. This is not mentioned in the video and matters for younger men.
• Men with a history of substance use disorder may need closer monitoring on TRT, not because testosterone is addictive in the clinical sense, but because dopaminergic reward pathways are already altered, and some research suggests this population deserves individualized assessment (Finley et al., 2020, Substance Abuse).

Brady's doctor told him to inject in the morning because he would want to be active. That is practical advice, not a red flag. But the framing of TRT as universally energizing without discussing the monitoring requirements leaves a gap that viewers should fill in with a real clinician, not more TikTok videos.